• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Clarification of Mechanism of Anti-microRNA-122 Therapy for Hepatitis C Virus Infection

Research Project

Project/Area Number 24790687
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Gastroenterology
Research InstitutionKanazawa University

Principal Investigator

SHIMAKAMI Tetsuro  金沢大学, 大学病院, 助教 (50436820)

Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
KeywordsC型肝炎ウイルス / microRNA-122 / C型慢性肝炎 / 抗ウイルス療法 / マイクロRNA122
Outline of Final Research Achievements

The emergence of Direct-Acting Antiviral Agents (DAA)-resistant virus could be a serious problem for the treatment of chronic hepatitis C patients. We examined the efficiency of the combination therapy with DAA and anti-miR-122 therapy, which is targeting liver-specific miRNA, miR-122. We demonstrated that the combination therapy (1) shows synergistic antiviral effect, (2) alleviates the drug resistance of DAA-resistance viruses, and (3)completely inhibits the emergence of DAA-resistance virus. These results indicate that anti-miR-122 therapy is quite useful in terms of inhibiting the emergence of DAA-resistance virus when it is combined with DAA.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (13 results)

All 2015 2014 2013 2012

All Journal Article (7 results) (of which Peer Reviewed: 7 results,  Open Access: 2 results) Presentation (6 results)

  • [Journal Article] Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C.2015

    • Author(s)
      Selitsky SR, Baran-Gale J, Honda M, Yamane D, Masaki T, Fannin EE, Guerra B, Shirasaki T, Shimakami T, Kaneko S, Lanford RE, Lemon SM, Sethupathy P.
    • Journal Title

      Sci Rep.

      Volume: 5 Issue: 1 Pages: 7675-7675

    • DOI

      10.1038/srep07675

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Regulation of the hepatitis C virus RNA replicase by2014

    • Author(s)
      Yamane D, McGivern DR, Wauthier E, Yi M, Madden VJ, Welsch C, Antes I, Wen Y, Chugh PE, McGee CE, Widman DG, Misumi I, Bandyopadhyay S, Kim S, Shimakami T, Oikawa T, Whitmire JK, Heise MT, Dittmer DP, Kao CC, Pitson SM, Merrill AH Jr, Reid LM, Lemon SM.
    • Journal Title

      Nature Medicine

      Volume: 20 Issue: 8 Pages: 927-35

    • DOI

      10.1038/nm.3610

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.2014

    • Author(s)
      Shirasaki T, Honda M, Shimakami T, Murai K, Shiomoto T, Okada H, Takabatake R, Tokumaru A, Sakai Y, Yamashita T, Lemon SM, Murakami S, Kaneko S.
    • Journal Title

      Hepatology.

      Volume: 60(5) Issue: 5 Pages: 1519-30

    • DOI

      10.1002/hep.27277

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The acyclic retinoid peretinoin inhibits hepatitis C virus replication and infectious virus release in vitro.2014

    • Author(s)
      Shimakami T, Honda M, Shirasaki T, Takabatake R, Liu F, Murai K, Shiomoto T, Funaki M, Yamane D, Murakami S, Lemon SM, Kaneko S.
    • Journal Title

      Sci Rep.

      Volume: 4 Issue: 1 Pages: 4688-4688

    • DOI

      10.1038/srep04688

    • NAID

      120005774911

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] hnRNP L and NF90 interact with hepatitis C virus 5'-terminal untranslated RNA and promote efficient replication.2014

    • Author(s)
      Li Y, Masaki T, Shimakami T, Lemon SM.
    • Journal Title

      Journal of Virology

      Volume: 88 Issue: 13 Pages: 7199-209

    • DOI

      10.1128/jvi.00225-14

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] microRNA-122 Abundance in Hepatocellular Carcinoma and Non-Tumor Liver Tissue from Japanese Patients with Persistent HCV versus HBV Infection.2013

    • Author(s)
      Spaniel C, Honda M, Selitsky SR, Yamane D, Shimakami T, Kaneko S, Lanford RE, Lemon SM.
    • Journal Title

      PLoS One

      Volume: 8(10) Issue: 10 Pages: e76867-e76867

    • DOI

      10.1371/journal.pone.0076867

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Base pairing between hepatitis C virus RNA and microRNA 122 3' of its seed sequence is essential for genome stabilization and production of infectious virus2012

    • Author(s)
      Shimakami T, Yamane D, Welsch C, Hensley L, Jangra RK, Lemon SM
    • Journal Title

      Journal of Virology

      Volume: 86 Pages: 7372-83

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] Regulation of Hepatitis C Virus Infection by Long Non-Coding RNAs.2014

    • Author(s)
      Shimakami T, Honda M, Shirasaki T, Liu F, Funaki M, Murai K, Shiomoto T, Murakami S, and Kaneko S.
    • Organizer
      The Liver Meeting 2014(65th Annual Meeting of the American Association for the Study of Liver Disease)
    • Place of Presentation
      ボストン(アメリカ)
    • Year and Date
      2014-11-13 – 2014-11-17
    • Related Report
      2014 Annual Research Report
  • [Presentation] Regulation of Hepatitis C Virus Infection by Long Non-Coding RNAs.2014

    • Author(s)
      Shimakami T, Honda M, Shirasaki T, Liu F, Funaki M, Murai K, Shiomoto T, Murakami S, and Kaneko S.
    • Organizer
      21st International Symposium on Hepatitis C Viruses
    • Place of Presentation
      バンフ(カナダ)
    • Year and Date
      2014-09-07 – 2014-09-11
    • Related Report
      2014 Annual Research Report
  • [Presentation] IL28B Genotype,ISGs発現量,前治療反応を用いたテラプレビル併用抗HCV 療法における治療効果予測と至適治療期間に関する検討2014

    • Author(s)
      島上哲朗、本多政夫、金子周一
    • Organizer
      第50回日本肝臓学会総会
    • Place of Presentation
      東京
    • Year and Date
      2014-05-29 – 2014-05-30
    • Related Report
      2014 Annual Research Report
  • [Presentation] 前治療無効例に対するテラプレビル併用3剤併用療法48週間延長投与に関する検討2014

    • Author(s)
      島上哲朗、本多政夫、金子周一
    • Organizer
      第100回日本消化器病学会総会
    • Place of Presentation
      東京
    • Year and Date
      2014-04-23 – 2014-04-26
    • Related Report
      2014 Annual Research Report
  • [Presentation] ACYCLIC RETINOID, PERETINOIN, INHIBITS HEPATITIS C VIRUS REPLICATION AND INFECTIOUS VIRUS RELEASE IN CELL2014

    • Author(s)
      Shimakami T, Honda M, Shirasaki T, Murakami S, and Kaneko S.
    • Organizer
      The 49th Meeting of the European Association for the Study of the Liver
    • Place of Presentation
      ロンドン(イギリス)
    • Year and Date
      2014-04-09 – 2014-04-13
    • Related Report
      2014 Annual Research Report
  • [Presentation] miR-122 stabilizes Hepatitis C Virus RNA by an Ago2-dependent mechanism2012

    • Author(s)
      Tetsuro Shimakami, Daisuke Yamane, Masao Honda, Shuichi Kaneke, and Stanley M Lemon
    • Organizer
      The 10th single topic conference (日本肝臓学会)
    • Place of Presentation
      京王プラザホテル(東京都)
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi